Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
Hyperphosphatemia in chronic kidney disease (CKD) has been associated with elevated cardiovascular morbidity and mortality. Serum phosphate control remains a cornerstone of the clinical management of patients with CKD, in order to both attenuate the progression of secondary hyperparathyroidism or bo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784056/ |